USD 0.0
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2012 | -3.7 Million USD | 0.03% |
2011 | -3.7 Million USD | -46.83% |
2010 | -2.52 Million USD | -525.55% |
2009 | -403.3 Thousand USD | 90.07% |
2008 | -4.06 Million USD | -4214.71% |
2007 | -94.13 Thousand USD | -119.05% |
2006 | -294.43 Thousand USD | 140.73% |
2005 | -1.21 Million USD | 6.75% |
2004 | -1.26 Million USD | -81.48% |
2003 | -774.87 Thousand USD | 78.29% |
2002 | -1.28 Million USD | -85.92% |
2001 | -1.77 Million USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2012 FY | - USD | 0.03% |
2012 Q1 | -678.78 Thousand USD | 47.36% |
2012 Q2 | -810.87 Thousand USD | -19.46% |
2012 Q3 | -918.43 Thousand USD | -13.27% |
2012 Q4 | -1.29 Million USD | -40.99% |
2011 FY | - USD | -46.83% |
2011 Q3 | -1.15 Million USD | -52.56% |
2011 Q4 | -1.28 Million USD | -11.57% |
2011 Q2 | -757.6 Thousand USD | -51.14% |
2011 Q1 | -501.26 Thousand USD | 32.06% |
2010 Q3 | -715.12 Thousand USD | -49.4% |
2010 Q4 | -737.82 Thousand USD | -3.17% |
2010 Q2 | -478.67 Thousand USD | 16.29% |
2010 FY | - USD | -525.55% |
2010 Q1 | -571.82 Thousand USD | -477.32% |
2009 Q3 | -64.22 Thousand USD | 40.6% |
2009 FY | - USD | 90.07% |
2009 Q1 | -131.9 Thousand USD | 24.8% |
2009 Q2 | -108.12 Thousand USD | 18.02% |
2009 Q4 | -99.04 Thousand USD | -54.22% |
2008 FY | - USD | -4214.71% |
2008 Q4 | -175.4 Thousand USD | -162.7% |
2008 Q3 | -66.76 Thousand USD | 98.21% |
2008 Q2 | -3.72 Million USD | -956.97% |
2008 Q1 | -351.97 Thousand USD | -251.13% |
2007 FY | - USD | -119.05% |
2007 Q4 | -100.24 Thousand USD | -108.86% |
2007 Q3 | 1.13 Million USD | 268.12% |
2007 Q2 | -672.91 Thousand USD | -48.78% |
2007 Q1 | -452.27 Thousand USD | -258.07% |
2006 FY | - USD | 140.73% |
2006 Q4 | 286.12 Thousand USD | -3.5% |
2006 Q3 | 296.5 Thousand USD | 34.84% |
2006 Q2 | 219.89 Thousand USD | 171.31% |
2006 Q1 | -308.36 Thousand USD | 39.56% |
2005 Q3 | 125.98 Thousand USD | 117.6% |
2005 Q2 | -715.82 Thousand USD | -533.04% |
2005 Q1 | -113.07 Thousand USD | 73.79% |
2005 FY | - USD | 6.75% |
2005 Q4 | -510.18 Thousand USD | -504.97% |
2004 Q1 | -333.02 Thousand USD | -154.08% |
2004 FY | - USD | -81.48% |
2004 Q4 | -431.48 Thousand USD | -486.05% |
2004 Q3 | -73.62 Thousand USD | 70.77% |
2004 Q2 | -251.91 Thousand USD | 24.36% |
2003 FY | - USD | 78.29% |
2003 Q1 | 5968.00 USD | 85.62% |
2003 Q3 | -327.58 Thousand USD | -15.7% |
2003 Q2 | -223.71 Thousand USD | 53.47% |
2003 Q4 | 497.08 Thousand USD | 271.96% |
2002 Q1 | -574.05 Thousand USD | 0.0% |
2002 Q3 | 1.05 Million USD | 199.76% |
2002 Q2 | -1.05 Million USD | -84.61% |
2002 FY | - USD | -85.92% |
2002 Q4 | -4.62 Million USD | -537.52% |
2001 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Dong Fang Hui Le Inc. | -25.71 Thousand USD | -14302.863% |
NexgenRx Inc. | 1.03 Million USD | 459.016% |
Pacific Health Care Organization, Inc. | 716.06 Thousand USD | 617.131% |